Get started
Author

Kristina Anatolyevna Akmalova

Observed names: K A Akmalova, K. A. Akmalova, K. Akmalova, K.A. Akmalova, K.A. Akmalova Akmalova, KA Akmalova, Kristina A. Akmalova, Kristina Akmalova, Kristina Anatolevna Akmalova, Акмалова К. А., Акмалова Кристина Анатольевна, К. А. Акмалова, К.А. Акмалова
ORCID: 0000-0003-3505-8520
Observed ORCID: 0000-0003-3505-8520
OpenAlex ID: A5010764677
Interethnic differences in the Prevalence of Main Cardiovascular Pharmacogenetic Biomarkers
2020 · Karin Mirzaev, Sherzod Abdullaev, et al. · Pharmacogenomics · 13
CYP2C9 gene polymorphisms influence on antihypertensive effectiveness and hypouricemic effect of losartan among patients with arterial hypertension: an observational study
2022 · Irina I. Sinitsina, Alexey V. Boyarko, et al. · Drug Metabolism and Personalized Therapy · 12
MicroRNAs as Novel Biomarkers for P2Y12 – Inhibitors Resistance Prediction
2021 · Eric Rytkin, Karin Mirzaev, et al. · Pharmacogenomics and Personalized Medicine · 11
PDF
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring
2021 · Eric Rytkin, Irina V. Bure, et al. · Drug Metabolism and Personalized Therapy · 11
The impact of ABCB1 , CYP3A4 and CYP3A5 gene polymorphisms on apixaban trough concentration and bleeding risk in patients with atrial fibrillation
2024 · Alena I. Skripka, Pavel M. Krupenin, et al. · Drug Metabolism and Personalized Therapy · 10
The effect of CYP2D6 and CYP2C9 gene polymorphisms on the efficacy and safety of the combination of tramadol and ketorolac used for postoperative pain management in patients after video laparoscopic cholecystectomy
2021 · Andranik Alexandrovich Muradian, Dmitry Alekseevich Sychev, et al. · Drug Metabolism and Personalized Therapy · 8
Pharmacogenetics of antipsychotics in adolescents with acute psychotic episode during first 14 days after admission: effectiveness and safety evaluation
2020 · Dmitriy V. Ivashchenko, Sofi Z. Khoang, et al. · Drug metabolism and drug interactions · 8
Clinically relevant pharmacogenetic markers in Tatars and Balkars
2020 · Shokhrukh Pardaboevich Abdullaev, Karin Badavievich Mirzaev, et al. · Molecular Biology Reports · 7
Effect of CYP2D6*4 , CYP2D6*10 polymorphisms on the safety of treatment with timolol maleate in patients with glaucoma
2022 · Larisa K. Moshetova, Maria M. Soshina, et al. · Drug Metabolism and Personalized Therapy · 6
Study of the Effect of Polymorphic Markers of the NAT2 Gene on the Risk of Adverse Drug Reactions in Patients with Pulmonary Tuberculosis Who Received Isoniazid and Rifampicin
2021 · A. A. Kachanova, Yu. A. Pimenova, et al. · Safety and Risk of Pharmacotherapy · 6
PDF
The polymorphic variants DRD2 rs1800497 and ABCB1 3435C>T are associated with antipsychotic safety parameters in adolescents with an acute psychotic episode: the results of a pilot study
2020 · D. V. Ivashchenko, S. Z. Khoang, et al. · Neurology neuropsychiatry Psychosomatics · 6
PDF
New Pharmacogenetic Markers to Predict the Risk of Bleeding During Taking of Direct Oral Anticoagulants
2020 · K. B. Mirzaev, D. V. Ivashchenko, et al. · Rational Pharmacotherapy in Cardiology · 6
Patients’ Pharmacogenetic Characteristics and the Risk of Adverse Reactions to Non-steroidal Anti-inflammatory Drugs: Case Reports
2024 · A. S. Zhiryakova, N. P. Denisenko, et al. · Safety and Risk of Pharmacotherapy · 5
PDF
CYP2D6 gene polymorphic markers role in determining the optimal treatment tactics for portal hypertension in patients with liver cirrhosis
2022 · Dmitry A. Sychev, Andrei I. Parusov, et al. · Terapevticheskii arkhiv · 4
PDF
Analysis of carrying clinically significant allelic variants of TPMT and DPYD genes associated with the response to drug therapy in cancer practice among 9 ethnic groups of the Russian Federation
2020 · K. B. Mirzaev, D. S. Fedorinov, et al. · Terapevticheskii arkhiv · 4
PDF
Correlation of 1846G>A Polymorphism of CYP2D6 Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic Hallucinoses
2025 · AA Parkhomenko, MS Zastrozhin, et al. · Psychopharmacology Bulletin · 3
Genetic Testing is Superior Over Endogenous Pharmacometabolomic Markers to Predict Safety of Haloperidol in Patients with Alcohol-induced Psychotic Disorder
2022 · Valentin Skryabin, Mikhail Zastrozhin, et al. · Current Drug Metabolism · 3
CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes
2021 · Dmitriy V. Ivashchenko, Daria A. Yudelevich, et al. · Drug Metabolism and Personalized Therapy · 3
Effect of polymorphisms in CYP3A4*22 (rs35599367) C>T, CYP3A5*3 (rs776746) A>G, ABCB1 (rs4148738) C>T and ABCB1 (rs1045642) C>T genes on apixaban anticoagulation: pilot study results
2021 · I. N. Sychev, L. V. Fedina, et al. · Meditsinskiy sovet = Medical Council · 3
PDF
Pharmacogenetics of the safety of phenazepam in alcohol withdrawal syndrome: haplotype and combinatorial analyses of polymorphic variants in the pharmacokinetic factor genes
2020 · D. V. Ivashchenko, O. V. Tereshchenko, et al. · Neurology neuropsychiatry Psychosomatics · 3
PDF
The role of CYP2C19 gene nucleotide sequence variants in assessing response to P2Y12 receptor inhibitor antiplatelet therapy in old patients with acute coronary syndrome
2026 · A. S. Markova, K. B. Mirzaev K. B., et al. · Rational Pharmacotherapy in Cardiology · 2
Prevalence of AOX1 and CYP1A2 gene polymorphisms associated with response to favipiravir therapy in novel coronavirus infection COVID-19 among ethnic groups of the North Caucasus
2025 · A. T. Leinsoo, N. P. Denisenko, et al. · Pharmacy & Pharmacology · 2
PDF
Genetic polymorphisms affect the metabolism of antituberculosis drugs
2025 · T. E. Tyulkova, A. P. Tkachuk, et al. · Pharmacogenetics and Pharmacogenomics · 2
Investigating the Use of Pharmacogenetic and Pharmacometabolomic Markers to Predict Haloperidol Efficacy and Safety Rates
2023 · Valentin Yurievich Skryabin, Mikhail Sergeevich Zastrozhin, et al. · Hospital Pharmacy · 2
PDF
HTR2A rs6313 polymorphic variant is associated with adverse effects to antipsychotics in adolescents with an acute psychotic episode
2021 · D.V. Ivashchenko Ivashchenko, N.I. Buromskaya Buromskaya, et al. · Фарматека · 2
Works count: 55
Citation count: 154
H-index: 7
I10-index: 5
Year
Topic
Type